Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil Dosages in ESWL
NCT01452880Phase 4Completed
- Sponsor
- Sapienza University of Rome
- Start
- Jan 2010
- Primary completion
- Jul 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of remifentanil in nephrolithiasis, sponsored by Sapienza University of Rome. Started Jan 2010; status: completed.
02
Drugs
remifentanil
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT01452880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01452880.